Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.
Technology solutions from early phase through to post-marketing.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
Developing transformative therapies requires a flexible approach.
Partners making a difference.
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
How modern monitoring paradigms impact CRA roles
A planning guide for health technology developers
Digital health technologies provide a roadmap for modernising clinical trials
ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
3 December 2025. Register now.
8 December 2025. Register now.
ICON CARES is our commitment to making a positive impact on our people, environment and our community.
Clinical Research. Evolved.
1:04:04
This webinar discusses how we can develop a methodology and minimum standards for migrating instruments that would be applicable to any device.
This webinar reviews the new European Medical Devices Regulation (MDR) and the In Vitro Diagnostic Medical Devices Regulation (IVDR)
49:54
34:00
